Both in Pharmaceuticals
Standard BioTools vs CAMP4 Therapeutics
Over the past year LAB returned −50.7% and CAMP returned −2.8%; their daily moves had a correlation of 0.08.
LAB −50.7% CAMP −2.8%Growth of $1, one year, split-adjusted
| Metric | LAB | CAMP |
|---|---|---|
| Price | $0.6108 | $3.83 |
| Market cap | $241.1M | $240.3M |
| Today | +0.15% | +1.46% |
| 1 month | −19.9% | −4.5% |
| 6 months | −37.6% | −3.8% |
| Year to date | −52.3% | −37.5% |
| 1 year | −49.1% | −7.9% |
| Revenue growth (YoY) | −7.6% | +18.8% |
| Gross margin | 52.4% | 100.0% |
| Net margin | −133.1% | −1884.8% |
| P/E (TTM) | 2.8× | — |
| Price / sales | 2.8× | 57.0× |
| Net cash | $476.4M | $86.4M |
| Dividend yield | — | — |
| Volatility (60d) | 45.5% | 83.9% |
| Short % of float | 1.1% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).